You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am 63 and was diagnosed with aggressive prostate cancer in ...
The active ingredient of Eligard® is leuprorelin acetate, a powder which is solubilized with a solvent for subcutaneous injection. Eligard® is available in three different dosages (for 1-month, ...
Dear Dr. Roach: I have been treated for prostate cancer and stopped my semiannual Eligard injections three years ago. I’m 75 years old and about 5 feet, 9 inches tall. Before treatment, I weighed 227 ...
"The six-month formulation provides physicians with a new convenientoption for patients with prostate cancer," said Bob Butchofsky, President andChief Executive Officer of QLT Inc. "Eligard sales have ...
Tolmar will resume the rights to ELIGARD® in the Canadian Market from Sanofi Canada BUFFALO GROVE, Ill., Oct. 8, 2021 /PRNewswire/ -- Tolmar, a specialty pharmaceutical company, today announced that, ...
> German biotech Medigene and Canada's QLT got E.U. approval for a six-month formulation of the sustained-delivery prostate cancer treatment Eligard. First-half sales of the drug reached almost $87 ...
In what its chairman and CEO called a “transforming event” for the company, Atrix Laboratories Inc. received FDA approval for Eligard 7.5 mg, its one-month treatment for advanced prostate cancer. The ...
Dr. Roach: I have been treated for prostate cancer and stopped my semiannual Eligard injections three years ago. I’m 75 years old and about 5 feet, 9 inches tall. Before treatment, I weighed 227 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback